Landec (LNDC) Stock Price, News & Analysis

Company Overview

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.

Key Stats

• Today's Range: N/A
• 50-Day Range: $8.05 to $9.95
• 52-Week Range: N/A
• Volume: 1,739 shs
• Average Volume: 84,032 shs
• Market Capitalization: $259.26 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Landec Stock Analysis - MarketRank™

Landec scored higher than 15% of companies evaluated by MarketBeat, and ranked 884th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Landec.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Landec are expected to grow in the coming year, from ($0.29) to $0.05 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Landec is -2.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Landec is -2.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for LNDC.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Landec does not currently pay a dividend.

Dividend Growth

Landec does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.4 / 5
• Environmental Score: -2.50

Short Interest

There is no current short interest data available for LNDC.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for LNDC on MarketBeat in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Landec insiders have not sold or bought any company stock.

Percentage Held by Insiders

14.61% of the stock of Landec is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

85.78% of the stock of Landec is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

LNDC Stock Analysis - Frequently Asked Questions

How were Landec's earnings last quarter?

Landec Co. (NASDAQ:LNDC) announced its quarterly earnings results on Tuesday, September, 28th. The basic materials company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.12. The basic materials company earned $128.79 million during the quarter, compared to the consensus estimate of $128.25 million. Landec had a negative trailing twelve-month return on equity of 16.79% and a negative net margin of 36.49%.

Does Landec have any subsidiaries?

Landec subsidiaries include these companies: Yucatan Foods, O Olive Oil, GreenLine Holding, Lifecore, Heartland Hybrids, Apio, Dock Resins, and Curation Foods Inc..

What other stocks do shareholders of Landec own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Landec investors own include Honda Motor (HMC), Comerica (CMA), Walt Disney (DIS), General Mills (GIS), Exxon Mobil (XOM), Cenovus Energy (CVE) and Intel (INTC).

Company Calendar

• Last Earnings: 9/28/2021
• Today: 1/23/2025
• Fiscal Year End: 5/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Specialty Chemicals
• Current Symbol: NASDAQ:LNDC
• CUSIP: 51476610
• CIK: 1005286
• Web: www.landec.com
• Phone: (650) 306-1650
• Fax: 650-368-9818
• Employees: 905
• Year Founded: 1986

Profitability

• EPS (Most Recent Fiscal Year): ($3.38)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-97,430,000.00
• Net Margins: -36.49%
• Pretax Margin: -20.04%
• Return on Equity: -16.79%
• Return on Assets: -6.38%

Debt

• Debt-to-Equity Ratio: 0.99
• Current Ratio: 1.40
• Quick Ratio: 0.63

Sales & Book Value

• Annual Sales: $185.79 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 2.55
• Book Value: $3.66 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 29,596,000
• Free Float: 25,272,000
• Market Cap: $259.26 million
• Optionable: Optionable
• Beta: 1.10